Sign in

Prof Shalini Vinod

@shalinivinod.bsky.social
55 followers 26 following 45 posts

Radiation Oncologist / #Lung Cancer / #Quality / #Equity

PostsRepliesMedia
Reposted by Prof Shalini Vinod
TROG Cancer Research @trogcancerresearch.bsky.social · 24/09/2026
The first site is now open at Peter MacCallum Cancer Centre, recruiting patients for the new TROG 21.10/TOGA 20-005 PRIME-Lung trial, exploring the role of RT in metastatic non-small cell lung cancer. Sites in Australia, Canada and Ireland will recruit for the study. trog.com.au/trog-prime-l...
011
Prof Shalini Vinod @shalinivinod.bsky.social · 04/08/2026
Great news for 🇦🇺 patients. Can’t wait to start recruiting patients.
020
Prof Shalini Vinod @shalinivinod.bsky.social · 31/07/2026
Today is World Lung Cancer Day. Time to reflect on the cancer responsible for the leading global cause of cancer deaths. Promote screening, reduce stigma and provide personalised patient centred care. @iaslc.bsky.social @togaanz.bsky.social @trogcancerresearch.bsky.social
010
Reposted by Prof Shalini Vinod
European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 20/07/2026
ESTRO clinical practice #guideline on high-dose thoracic #reirradiation for non-small cell #lungcancer: abstract published in the #GreenJournal. 👉 bit.ly/4yuCJdR #radonc #radiotherapy #NSCLC
021
Prof Shalini Vinod @shalinivinod.bsky.social · 16/07/2026
Great talk by Rad Onc Prof Sara Ramella on the need to consider dose to lymphocytes/ immune system during chemo RT for #NSCLC. @togaanz.bsky.social @trogcancerresearch.bsky.social
010
Prof Shalini Vinod @shalinivinod.bsky.social · 15/07/2026
269 primary lung cancers diagnosed in 1st year of 🇦🇺lung cancer screening program with good screening uptake in rural communities and First Nations population. @togaanz.bsky.social #TOGA2026 @drtomjohn.bsky.social @dkarikios.bsky.social
051
Prof Shalini Vinod @shalinivinod.bsky.social · 02/07/2026
Happy 1y Birthday to the Australian National Lung Cancer Screening Programme 🎉🥳 102500 people screened, 1400 identified as high risk, >200 cancers diagnosed. Many lives saved. www.health.gov.au/our-work/nlc... @togaanz.bsky.social
health.gov.au
011
Prof Shalini Vinod @shalinivinod.bsky.social · 13/06/2026
Do you know how your patients feel about exposing themselves for #radiotherapy? 👉🏽The Bare Essentials: Exploring Modesty Concerns to Enhance Radiation Therapy Practice and Patient Care - Practical Radiation Oncology www.practicalradonc.org/article/S187...
practicalradonc.org
The Bare Essentials: Exploring Modesty Concerns to Enhance Radiation Therapy Practice and Patient Care
Modesty affects patient experience of health care and health outcomes. Radiation therapy often requires body exposure. Little is known about modesty and patient unease during radiation therapy across ...
031
Reposted by Prof Shalini Vinod
TROG Cancer Research @trogcancerresearch.bsky.social · 18/05/2026
We're thrilled to have run the life-changing TROG 15.03/ANZUP 16001 FASTRACK II trial led by Prof Shankar Siva. Fantastic to see these impactful results.
031
Reposted by Prof Shalini Vinod
TROG Cancer Research @trogcancerresearch.bsky.social · 18/05/2026
Exciting findings: FASTRACK II trial 5-years outcomes presented at #ESTRO26 & in @thelancetoncol.bsky.social l show SABR achieves 100% effectiveness in treating primary kidney cancers @anzuptrials.bsky.social trog.com.au/fastrack-ii-...
011
Reposted by Prof Shalini Vinod
TROG Cancer Research @trogcancerresearch.bsky.social · 20/05/2026
It's been fabulous to see so many TROG trials in the spotlight at the @estroradiotherapy.bsky.social meeting in Sweden this week. Congrats to all the researchers who presented on impactful trial findings & innovative radiation therapy quality assurance initiatives. trog.com.au/trog-trials-...
trog.com.au
TROG trials in the spotlight at ESTRO26 international conference - TROG Cancer Research
LATEST NEWS: 20 MAY A number of TROG trials and projects garnered international attention this month, as researchers presented findings at one of the world’s largest radiotherapy and oncology meetings...
021
Reposted by Prof Shalini Vinod
TOGA @togaanz.bsky.social · 27/05/2026
Final days to secure early bird rates for the 2026 TOGA ASM. Be part of an engaging scientific program bringing together experts across research, clinical care, and innovation in thoracic oncology. Early Bird Registrations close 31 May. Clinicians save up to 45%
222
Prof Shalini Vinod @shalinivinod.bsky.social · 09/06/2026
Excited to share our publication on adaptive CBCT for #lungcancer #radiotherapy. Faster acquisition & reduced radiation dose www.phiro.science/article/S240...
020
Prof Shalini Vinod @shalinivinod.bsky.social · 14/05/2026
5 patients recruited. Eagerly waiting for other centres to get on board. Not many Rad Onc trials have QOL as primary endpoint. image-x.sydney.edu.au/the-vital-cl...
image-x.sydney.edu.au
The VITaL Clinical Trial - Image X Institute
The VITaL Clinical Trial is testing a new method for lung cancer radiotherapy. Learn about the VITaL Clinical Trial, information for people considering taking part in the trial.
020
Prof Shalini Vinod @shalinivinod.bsky.social · 13/05/2026
Median age of patients with lung cancer =70y. What are the unmet needs of older people living with lung cancer? academic.oup.com/ageing/artic...
academic.oup.com
Exploring the unmet needs of older people living with lung cancer: a qualitative study
Abstract Research into unmet needs in older populations with cancer is crucial, as existing studies often overlook these groups and fail to capture their u
021
Prof Shalini Vinod @shalinivinod.bsky.social · 13/05/2026
Ever wondered whether more intensive strategies increase uptake of lung cancer screening? Trial protocol here. Results @iaslc.bsky.social WCLC2026 link.springer.com/article/10.1...
link.springer.com
Ready to screen implementation trial protocol: a cluster randomized implementation trial comparing a bundled implementation strategy versus a simple implementation strategy to improve intention to scr...
Background Uptake of lung cancer screening (LCS) in high-risk populations remains suboptimal internationally. Primary care practitioners play a critical role in identifying eligible patients and initi...
020
Prof Shalini Vinod @shalinivinod.bsky.social · 13/05/2026
Introducing a new global lung cancer community to provide patients & carers with information & resources about lung cancer know-lungcancer.com
know-lungcancer.com
Home | Know Lung Cancer
Know Lung Cancer is a global education and awareness initiative that provides patients and caregivers with the information, resources, and support they need to deal with lung cancer.
010
Prof Shalini Vinod @shalinivinod.bsky.social · 16/11/2025
Thrilled at launch of 🇦🇺 optimal care pathways for older people with #cancer #COSAASM2025 www.cancer.org.au/assets/pdf/o...
041
Prof Shalini Vinod @shalinivinod.bsky.social · 16/11/2025
Honoured to receive NSW health research award for our nurse-led geriatric oncology model of care for older patients with #lungcancer Innovative sustainable models essential in translating evidence into practice @nsw-health.bsky.social
010
Reposted by Prof Shalini Vinod
IASLC @iaslc.bsky.social · 01/11/2025
It’s Lung Cancer Awareness Month 💙. Research improves outcomes for the world’s deadliest cancer. The IASLC community works to conquer lung cancer every day. Help fund critical research and make an impact: bit.ly/4nBZ6HU
062
Prof Shalini Vinod @shalinivinod.bsky.social · 10/10/2025
Important to assess quality of decision making at MDMs. Is the patient voice being heard? Do nurses contribute? www.sciencedirect.com/science/arti...
sciencedirect.com
Quality of Decision-making at Oncology Multidisciplinary Team Meetings: A Structured Observational Study
Multidisciplinary meetings (MDMs) are crucial in cancer care, with increasing attention on improving the quality of decision-making. Validated tools h…
000
Prof Shalini Vinod @shalinivinod.bsky.social · 10/10/2025
Pleasure to be part of this podcast about treating older people with #lungcancer thoraciconcology.org.au/podcasts/59-... @togaanz.bsky.social @dkarikios.bsky.social @tomjohnston2796.bsky.social
thoraciconcology.org.au
59 - Challenging Ageism: Optimising Lung Cancer Treatment in Older Adults - TOGA - Thoracic Oncology Group Australasia
In this episode of Conversations in Lung Cancer Research, hosted by Dr Michael Krasovitsky, a medical oncologist at St. Vincent's Hospital in Sydney, the focus is on lung cancer in older adults.
011
Reposted by Prof Shalini Vinod
The Lancet Oncology @thelancetoncol.bsky.social · 07/09/2025
Super session announcing a new @thelancet.com @iaslc.bsky.social Commission on lung cancer at this year’s WCLC 2025 in Barcelona
021
Prof Shalini Vinod @shalinivinod.bsky.social · 07/09/2025
Excited to be a commissioner for Lancet Commission on Lung Cancer www.lancetlungcancer.org @iaslc.bsky.social @thelancet.com
lancetlungcancer.org
The IASLC - Lancet Commission on Lung Cancer
The IASLC - Lancet Commission on Lung Cancer brings together leading clinicians, researchers, policymakers, and patient advocates from across the globe aiming to reframe the global lung cancer agenda.
000
Reposted by Prof Shalini Vinod
hannaradonc.bsky.social @hannaradonc.bsky.social · 05/09/2025
Are you thinking of studying the association of the time from cancer diagnosis to treatment and overall survival? Have a look at these consensus recommendations we developed and published in the British Journal of Cancer: www.nature.com/articles/s41...
nature.com
Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi process - British Journal of Cancer
British Journal of Cancer - Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi process
031
Prof Shalini Vinod @shalinivinod.bsky.social · 31/07/2025
3694 people enrolled for lung cancer screening in first month of lung cancer screening in 🇦🇺 👏🏽👏🏽👏🏽 @racgp.bsky.social @togaanz.bsky.social
011
Prof Shalini Vinod @shalinivinod.bsky.social · 17/07/2025
A #nurse led geriatric oncology model of care is a feasible way of ⬆️ geriatric screening & assessment of older adults with #cancer. www.sciencedirect.com/science/arti...
sciencedirect.com
Implementation and evaluation of a nurse-led geriatric oncology model of care for older adults with lung cancer
000
Prof Shalini Vinod @shalinivinod.bsky.social · 17/07/2025
🙏🏽 @medacape.com for showcasing #lungcancer screening in 🇦🇺 www.medscape.com/viewarticle/...
medscape.com
Australia Launches Lung Cancer Screening Program for Smokers
Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial low-dose CT scans.
000
Prof Shalini Vinod @shalinivinod.bsky.social · 30/06/2025
Lung cancer screening in 🇦🇺is finally here! Amazing amount of work from multidisciplinary group & consumers. www.health.gov.au/our-work/nlcsp Need @racgp.bsky.social support to assess patients for eligibility. It’s time to ⬆️ survival from lung cancer! @dkarikios.bsky.social @drtomjohn.bsky.social
health.gov.au
031
Reposted by Prof Shalini Vinod
hannaradonc.bsky.social @hannaradonc.bsky.social · 11/06/2025
The Onus of Proof: Evidence-Based Adoption of Advanced Radiation Therapy Technologies. www.redjournal.org/article/S036...
redjournal.org
The Onus of Proof: Evidence-Based Adoption of Advanced Radiation Therapy Technologies
Historically, there has been a relative paucity of randomized controlled trials (RCTs) in radiation oncology relative to the number in medical oncology. In an analysis of almost 700 RCTs published bet...
021
Prof Shalini Vinod @shalinivinod.bsky.social · 04/06/2025
🙏🏽 ABC for shining the light on 🇦🇺 deadliest cancer. Bring on #lungcancer screening www.abc.net.au/news/2025-06... @abcnewsbot.bsky.social @gerryhanna.bsky.social @drtomjohn.bsky.social @dkarikios.bsky.social @bensolomon1.bsky.social
abc.net.au
Australia's deadliest cancer to get new screening program
After years of lobbying from patients, the first ever national lung cancer screening program will roll out next month for people who have a significant history of smoking.
062
Prof Shalini Vinod @shalinivinod.bsky.social · 04/06/2025
Need exercise physiologists as routine members of oncology team esp for survivorship care
010
Prof Shalini Vinod @shalinivinod.bsky.social · 31/05/2025
👏🏽👏🏽👏🏽 work by PhD student Dr Kim-Lin Chiew - Quality Indicators and Benchmarks for Radiotherapy in Lung Cancer: A Modified Delphi Approach - Clinical Oncology www.clinicaloncologyonline.net/article/S093... @gerryhanna.bsky.social
clinicaloncologyonline.net
Quality Indicators and Benchmarks for Radiotherapy in Lung Cancer: A Modified Delphi Approach
While there are many published quality indicators (QIs) for assessing clinical care in lung cancer few specifically measure the quality of radiotherapy (RT). To address this gap, we used a structured ...
010
Prof Shalini Vinod @shalinivinod.bsky.social · 27/05/2025
🇦🇺lung cancer screening coming 1st July. Guidelines state “ Suitability for lung cancer surgery should not be a contraindication for screening, as those with comorbidities can safely be Rx with radiotherapy (SABR) with minimal toxicities”. www.targetingcancer.com.au/dereks-story/ @racgp.bsky.social
targetingcancer.com.au
Derek’s Story - Radiation Oncology Targeting Cancer
A game-changing radiation therapy technique called SABR is offering hope to people living with lung cancer, like Derek Peffe
000
Prof Shalini Vinod @shalinivinod.bsky.social · 25/05/2025
Guidance on appropriate imaging in FU after #lungcancer Rx. Highly variable in practice. Time for #commonsenseoncology www.sciencedirect.com/science/arti... @iaslc.bsky.social @astro-org.bsky.social @gerryhanna.bsky.social @drtomjohn.bsky.social @dkarikios.bsky.social @hannaradonc.bsky.social
sciencedirect.com
ACR Appropriateness Criteria® Lung Cancer-Surveillance After Therapy
This document reviews the evidence supporting different imaging modalities and techniques used to evaluate patients with a history of lung cancer. It …
043
Prof Shalini Vinod @shalinivinod.bsky.social · 13/05/2025
Fascinating research on how a simple photo can be used to predict survival in cancer patients. FaceAge, a deep learning system to estimate biological age from face photographs to improve prognostication: a model development and validation study www.thelancet.com/journals/lan...
thelancet.com
FaceAge, a deep learning system to estimate biological age from face photographs to improve prognostication: a model development and validation study
Our results suggest that a deep learning model can estimate biological age from face photographs and thereby enhance survival prediction in patients with cancer. Further research, including validation...
000
Prof Shalini Vinod @shalinivinod.bsky.social · 13/05/2025
Great work @nicoleranski.bsky.social on psychosocial influencers & barriers for #lungcancer screening www.sciencedirect.com/science/arti...
sciencedirect.com
Psychosocial impacts of, and barriers to, lung cancer screening: an international qualitative study of multidisciplinary health professionals’ perspectives
Many lung cancer screening (LCS) programs are in development following landmark trials demonstrating the effectiveness of screening for reducing lung …
000
Prof Shalini Vinod @shalinivinod.bsky.social · 13/05/2025
Excited to obtain funding for #radiotherapy RCT of functional lung avoidance in lung cancer radiotherapy www.sydney.edu.au/news-opinion... @sydney.edu.au
sydney.edu.au
Sydney researchers awarded new funding for clinical trials and cohort studies
University of Sydney medicine and health researchers awarded over $8 million under the National Health and Medical Research Council Clinical Trials and Cohort Studies grant scheme.
000
Reposted by Prof Shalini Vinod
OncoDaily @oncodaily.bsky.social · 03/05/2025
TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer @estroradiotherapy.bsky.social oncodaily.com/opinion/topg... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESTRO25 #ESTRO2025 #GastricCancer #TOPGEAR #CRT #GEJ
oncodaily.com
TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer - OncoDaily
TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer / cancer, ESTRO, ESTRO 2025, gastric cancer, Headlines, Leong
0123
Prof Shalini Vinod @shalinivinod.bsky.social · 29/04/2025
🇦🇺 guidelines for #lungcancer screening. Screening coming 1st July. Great step forward in #lungcancer Mx. Spread the word. www.health.gov.au/our-work/nlc... @newsgp.bsky.social @ausgov.bsky.social @drtomjohn.bsky.social @bensolomon1.bsky.social @dkarikios.bsky.social
health.gov.au
032
Prof Shalini Vinod @shalinivinod.bsky.social · 26/04/2025
👏🏽🎉Dr Vicky Chin on being awarded the Frank Ellis medal for greatest contribution to advancing the science of cancer treatment in 2023 Clinical Oncology. pubmed.ncbi.nlm.nih.gov/36964031/ @unsw.bsky.social @gerryhanna.bsky.social #Cardiooncology #PhD
pubmed.ncbi.nlm.nih.gov
Validation of a Fully Automated Hybrid Deep Learning Cardiac Substructure Segmentation Tool for Contouring and Dose Evaluation in Lung Cancer Radiotherapy - PubMed
The novel hybrid automatic segmentation tool reported high accuracy and consistency over a validation set with challenging anatomical and imaging variations. This has promising applications in substru...
042
Prof Shalini Vinod @shalinivinod.bsky.social · 26/04/2025
@hannaradonc.bsky.social
010
Prof Shalini Vinod @shalinivinod.bsky.social · 23/04/2025
Clinicians have their own specialty bias for Rx on NSCLC. Hardly surprising but how can we ensure balanced opinions for patients? Should they see all treating specialists? www.sciencedirect.com/science/arti... @iaslc.bsky.social @patientadvocacy.bsky.social
sciencedirect.com
Physician Specialty Shapes Hypothetical Self-Treatment Choices for Locally 2 Advanced Non-Small Cell Lung Cancer: Is the 'Best' Option Subjective?
Recent trials show evolving paradigms in systemic therapy improve outcomes for select patients with resectable non-small-cell lung cancer (NSCLC). How…
000
Prof Shalini Vinod @shalinivinod.bsky.social · 23/04/2025
Clinical trials of systemic Rx in NSCLC NOT assoc with time toxicity in Canada! jamanetwork.com/journals/jam...
jamanetwork.com
Health Care Contact Days for NSCLC Treated in Clinical Trials vs Routine Care
This cohort study examines patterns of contact days among patients with advanced-stage non–small cell lung cancer receiving care in clinical trials compared with routine practice.
011
Prof Shalini Vinod @shalinivinod.bsky.social · 23/04/2025
Surveillance with FDG PET/CT does not improve rates of curatively treated recurrences, TTR, or OS compared to ceCT in NSCLC patients after curative treatment. www.sciencedirect.com/science/arti...
sciencedirect.com
Surveillance with [18F]FDG PET/CT of stage I-III lung cancer patients after completion of curative treatment (SUPE_R): a randomized controlled trial
Post-treatment surveillance is recommended for non-small cell lung cancer (NSCLC) due to a high risk of recurrence, but evidence on the optimal survei…
000
Prof Shalini Vinod @shalinivinod.bsky.social · 06/04/2025
Guideline on Dx & Rx of radiation pneumonitis. Hope to investigate functional lung RT planning to limit this toxicity. www.sciencedirect.com/science/arti... @drdavidpalma.bsky.social
sciencedirect.com
Diagnosis and treatment of radiation induced pneumonitis in patients with lung cancer: An ESTRO clinical practice guideline
The incidence of radiation pneumonitis (RP) has decreased significantly compared to historical series, mainly due to improved radiotherapy techniques …
000
Prof Shalini Vinod @shalinivinod.bsky.social · 03/04/2025
Engineering meets medicine. ⬇️scan time 63% ⬇️ radiation 85% for CBCT imaging of lung tumours. www.nature.com/articles/s44... @sydney.edu.au @radiotherapy.bsky.social
nature.com
Real-time spatiotemporal optimization during imaging - Communications Engineering
Dillon et al. developed a new computational approach for optimizing CT-based image guidance for lung cancer radiation therapy. Monitoring the patient while controlling the imaging hardware in real tim...
000
Prof Shalini Vinod @shalinivinod.bsky.social · 20/03/2025
LMIC study shows that chemo RT for cervical cancer improves QOL including in HIV+ pts gh.bmj.com/content/10/3... @upenn.edu @upenn.bsky.social #globalhealth #cervixcancer
gh.bmj.com
Longitudinal study on quality of life following cervical cancer treatment in Botswana
Purpose This study longitudinally assessed the quality of life (QoL) in patients who completed chemoradiation (CRT) for cervical cancer in Botswana and compared the QoL for those living with and witho...
000
Prof Shalini Vinod @shalinivinod.bsky.social · 19/03/2025
It’s never too late to quit smoking! www.unsw.edu.au/newsroom/new...
unsw.edu.au
‘Never too late’: quitting smoking after cancer diagnosis boosts survival rates, modelling shows
People who quit smoking after a cancer diagnosis can still improve the length and quality of their life, new modelling shows.
100
Reposted by Prof Shalini Vinod
Annie Wong 黃毅敏 @anmwongnz.bsky.social · 12/03/2025
What an inspiring video to wake up to! 🙌find strength in your team 🙌defend what is right 🙌you can do ANYTHING but not everything 🙌fight imposter syndrome - you deserve to be there youtu.be/i6fe2EK2lh8?... @solangepeters.bsky.social @drjnaidoo.bsky.social #ESMO #Women4Oncology #oncology
youtu.be
Diary of an oncology leader: Episode 1 – Solange Peters
YouTube video by European Society for Medical Oncology (ESMO)
0125